{"id":353259,"date":"2016-04-04T10:46:44","date_gmt":"2016-04-04T15:46:44","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-law\/injury\/product-liability\/evista.html"},"modified":"2025-10-07T18:56:00","modified_gmt":"2025-10-07T23:56:00","slug":"evista","status":"publish","type":"page","link":"https:\/\/www.findlaw.com\/injury\/product-liability\/evista.html","title":{"rendered":"Evista Legal Information"},"content":{"rendered":"\n
\n

Evista Legal Information<\/h1>\n\n
\n
\n By Christie Nicholson, J.D.<\/a> | Legally reviewed by Oni Harton, J.D.<\/a>\n | Last updated\n
\n \n <\/i>\n Legally Reviewed\n <\/summary>\n\n
\n

This article has been written and reviewed for legal accuracy, clarity, and style by FindLaw\u2019s team of legal writers and attorneys<\/a> and in accordance with our editorial standards<\/a>.<\/em><\/p>\n\n <\/div>\n <\/details>\n\n

\n \n <\/i>\n Fact-Checked\n <\/summary>\n\n
\n

The last updated date refers to the last time this article was reviewed by FindLaw or one of our contributing authors<\/a>. We make every effort to keep our articles updated. For information regarding a specific legal issue affecting you, please contact an attorney in your area<\/a>.<\/em><\/p>\n\n <\/div>\n <\/details>\n<\/section>\n\n\n

\n

Evista<\/span> was originally approved to treat osteoporosis<\/span> but was later marketed off-label<\/span> for breast cancer<\/span> prevention, leading to a $36 million government fine for misbranding. Clinical trials<\/span> revealed that while Evista<\/span> reduced breast cancer<\/span> risk, it significantly increased the risk of blood clots<\/span> and fatal strokes in postmenopausal women<\/span>.<\/p>\n\n <\/div>\n\n\n\n

Evista<\/span>\u00a0(raloxifene<\/span>)\u00a0is used to prevent and treat\u00a0osteoporosis<\/span> in postmenopausal women<\/span>. Evista<\/span>\u00a0works like estrogen to stop bone loss in women after menopause. Clinical trials<\/span> have shown that Evista<\/span> may also help reduce the risk of invasive <\/span>breast cancer<\/span> in postmenopausal women<\/span>.<\/p>\n

Eli Lilly<\/span> and Company<\/span> manufactures Evista<\/span>. The U.S. Food and Drug Administration<\/span> (FDA) approved the drug in 1999<\/a>. While regulators never approved Evista<\/span> for reducing the risk of invasive <\/span>breast cancer<\/span> in postmenopausal women<\/span>, Eli Lilly<\/span> and Company<\/span> started marketing the drug for this off-label<\/span> use<\/span>.<\/p>\n

For more than five years, patients took the drug without issue. However, in 2006, clinical trials<\/span> confirmed that Evista<\/span> also increased a patient\u2019s risk of blood clots<\/span> and stroke.<\/p>\n

This section discusses the side effects<\/span> and adverse interactions of Evista<\/span>. It also provides a timeline of news and research events related to Evista<\/span>. You\u2019ll also learn what to do if you develop blood clots<\/span> or another health issue after taking this medication.<\/p>\n

Pharmaceutical companies<\/span> have a legal responsibility to ensure their medications carry adequate warnings and are safe to use. If you\u2019ve been harmed by Evista<\/span> or another drug, you have legal rights. Contact a product liability<\/span> attorney<\/a> near you to share your story and learn your legal options.<\/p>\n

Benefits and Adverse Reactions to Evista<\/span><\/h2>\n

Many patients have benefitted from taking Evista<\/span><\/a>. However, others have experienced severe side effects<\/span> after taking the drug.<\/p>\n

A study published in the\u00a0New England Journal of Medicine in 2006<\/a>\u00a0revealed evidence that postmenopausal women<\/span> who took Evista<\/span> developed significantly fewer cases of breast cancer<\/span> than women who took a placebo<\/span>. The study also showed that they had substantially more fatal strokes and potentially dangerous blood clots<\/span>.<\/p>\n

Common Side Effects<\/span> of Evista<\/span><\/h2>\n

Evista<\/span> doesn\u2019t stimulate the uterus or breast. You should tell your doctor if you experience vaginal bleeding, breast pain, or enlargement. These could be signs of more severe health issues.<\/p>\n

You should tell your healthcare<\/span> professional if any of the\u00a0following symptoms<\/a>\u00a0are severe or persistent:<\/p>\n